Pharmaceutical

US lawmakers urge administration to take action against...

A bipartisan group of lawmakers is seeking an investigation and sanctions agains...

SCOPE: Changing protocol language and site actions are ...

A panel at the 2024 SCOPE Summit shared their experiences of setting up and runn...

FDA cracks down on online retailers selling unapproved ...

The FDA has issued warning letters to two online sellers for selling unapproved ...

BMS signs $674m GenAI drug discovery deal with VantAI

The partnership will focus on designing molecular glues for unspecified therapeu...

Grifols gears up for FDA approval of fibrinogen replace...

Grifols’ Phase III AdFIrst trial met its primary endpoint and the company plans ...

Sudo secures additional funds to advance TYK2 inhibitor...

Sudo Biosciences secured $30m in second round of Series B funding to further the...

STAT+: FDA advisory panel votes in favor of Abbott’s ne...

A Food and Drug Administration advisory panel lent its support to Abbott's new d...

STAT+: Lawmakers eye partial increase for Medicare doct...

Lawmakers are considering increasing doctors’ Medicare pay in an upcoming govern...

STAT+: Private equity investment in Medicare Advantage ...

Private equity investors made only 4 investments in Medicare Advantage-related c...

STAT+: Biogen Alzheimer’s drug launch off to slow start

While just 2,000 Alzheimer's patients are currently taking Leqembi, an additiona...

The need to know biotech news stories today

A new study shows that people vaccinated against Ebola  with a single dose of Me...

STAT+: Pharmalittle: We’re reading about a tossed PhRMA...

A U.S. district judge granted a Biden administration request to dismiss a PhRMA ...

STAT+: Startup BioAge raises $170 million Series D for ...

A California biotech developing a combination therapy with the blockbuster obesi...

STAT+: KalVista pill reduces swelling symptoms caused b...

Patients with herditary angioedema may soon get a pill alternative to the inject...

Opinion: STAT+: A California court is setting a dangero...

A California court is setting a dangerous precedent over drug development.

Was Pfizer’s ‘Here’s to Science’ commercial during the ...

Super Bowl ads are an opportunity for brands to put their work in front of more ...